63323-415 : Neostigmine Methylsulfate 1 mg/ml Intravenous Injection, Solution


NDC: 63323-415
Labeler: Fresenius Kabi USA, LLC
Product Type: Human Prescription Drug
Drug Name: Neostigmine Methylsulfate
Dosage Form: Intravenous Injection, Solution
Application #: NDA203629
Rev. Date: 


NDC Package Codes:

  • 63323-415-10: 10 VIAL, MULTI‑DOSE IN 1 TRAY (63323‑415‑10) > 10 ML IN 1 VIAL, MULTI‑DOSE
  • 63323-415-36: 10 VIAL, MULTI‑DOSE IN 1 TRAY (63323‑415‑36) > 10 ML IN 1 VIAL, MULTI‑DOSE

Active Ingredients:

  • Neostigmine Methylsulfate

Dosage Strength:

  • 1 mg/mL

Pharmaceutical Classes:

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 63323-382 Neostigmine Methylsulfate 5 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Fresenius Kabi USA, LLC
  • 63323-383 Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by Fresenius Kabi USA, LLC
  • 63323-413 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
  • 65219-811 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
  • 76045-214 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
  • 76045-383 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
  • 0404-9925 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Henry Schein, Inc.
  • 0517-0033 Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by American Regent, Inc.
  • 0517-0034 Neostigmine Methylsulfate .5 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by American Regent, Inc.
  • 0517-1133 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by American Regent, Inc.
  • 0517-1134 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by American Regent, Inc.
  • 0548-9601 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Amphastar Pharmaceuticals, Inc.
  • 0548-9602 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Amphastar Pharmaceuticals, Inc.
  • 0641-6076 Neostigmine Methylsulfate .5 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6077 Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6140 Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6141 Neostigmine Methylsulfate .5 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6149 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp.
  • 0641-6150 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp.
  • 0641-6240 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63323-415 QR Code

< Prev: 63323-413Next: 63323-416 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.